Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...

A study of 2.5 million women aged 65 years or older found a 0.7% prevalence of vulvar lichen sclerosus (VLS), and those with VLS had an 11-fold higher risk of developing vulvar squamous cell carcinoma ...

Precision medicine is looking increasingly promising in advanced vulvar squamous cell carcinomas (VSCCs), which make up 90% of vulvar cancers. The emergence of molecular stratification provides ...

Vulvar and cervical cancers affect thousands of women each year, particularly in low and middle-income countries. In 2022, the World Health Organization estimated that about 94% of the deaths caused ...

A new study of female Medicare beneficiaries reveals that vulvar lichen sclerosus affects 7 out of every 1,000 women aged 65 and older, significantly higher than rates seen in younger populations. The ...

Vulvar cancer is a less common gynecological cancer. HPV infection, smoking, and having a precancerous condition called vulvar intraepithelial neoplasia all increase the risk. Outlook for vulvar ...

Gynecological cancers affect the reproductive organs of people who were assigned female at birth (AFAB). They include cancers of the: Cervix Ovaries Uterus Vagina Vulva A sixth type is a very rare ...

Stage 2 vaginal cancer involves spread beyond the vaginal wall but not to the pelvic sidewall, with symptoms like abnormal bleeding and pain during intercourse. Diagnosis includes pelvic exams, ...

While a vulvar or vaginal lump can be a symptom of cancer, it’s usually caused by less serious conditions. Vulva and vaginal cancer are fairly rare, so if you have a pubic lump, it’s likely caused by ...